Patterson-UTI Energy Inc (PTEN)

PTEN (NASDAQ:Energy) EQUITY
$11.83
neg -0.76
-6.00%
Today's Range: 11.81 - 12.51 | PTEN Avg Daily Volume: 5,107,000
Last Update: 02/11/16 - 12:34 PM EST
Volume: 2,006,349
YTD Performance: -16.51%
Open: $12.28
Previous Close: $12.59
52 Week Range: $10.94 - $23.11
Oustanding Shares: 147,178,930
Market Cap: 1,882,418,515
6-Month Chart
TheStreet Ratings Grade for PTEN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 8 8 7
Moderate Buy 1 2 1 1
Hold 7 7 7 7
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.06 2.06 2.13
Latest Dividend: 0.10
Latest Dividend Yield: 3.13%
Dividend Ex-Date: 03/08/16
Price Earnings Ratio: -6.40
Price Earnings Comparisons:
PTEN Sector Avg. S&P 500
-6.40 0.00 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-22.48% -24.97% -46.36%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.20 -0.31 -0.11
Net Income -100.00 -1.98 0.00
EPS -100.00 -2.02 0.00
Earnings for PTEN:
EBITDA 0.57B
Revenue 1.89B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $-0.53 $-0.57 $-2.16 $-1.73
Number of Analysts 13 13 15 15
High Estimate $-0.48 $-0.46 $-1.62 $-0.70
Low Estimate $-0.55 $-0.62 $-2.37 $-2.46
Prior Year $0.06 $-0.13 $-0.66 $-2.16
Growth Rate (Year over Year) -987.18% -334.91% -226.67% 19.85%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Not many, according to filings from Tweedy Browne and Kahn Brothers.
Irving Kahn's eight decades of value investing  helps, too.
But it's losing some of its luster.
Ben Graham's method for substitution approach is now a classic.
Bearish
Oct 27, 2014 | 7:25 AM EDT
PTEN downgraded to Neutral from Conviction List Buy, said Goldman. With WTI projected to average $74 in 2015, customer capital spending...
I am more optimistic about some of the larger onshore plays.
The analysts tend to be trend followers.
Bullish
Mar 17, 2014 | 7:40 AM EDT
PTEN was upgraded from Neutral to Buy, Goldman Sachs said. Company was also placed on the Conviction List. $37 price target. Expect hig...
Bullish
Jan 08, 2014 | 7:09 AM EST
PTEN was upgraded from Sector Perform to Outperform, RBC Capital said. $29 price target. Company is growing its position in the Tier 1 ...
Bullish
Oct 28, 2013 | 7:51 AM EDT
PTEN was upgraded from Sell to Neutral, Goldman Sachs said. $25 price target. Valuation call, as the stock has lagged its peers in rece...

Columnist Conversations

Well said, Jim C. To me it isn't so much as the Federal Reserve is missing a moment as we keep giving them the...
Possible SEC accounting investigation
The top three biotechnology picks we have at Shark Biotechnology right now are FGEN, RARE and BMRN
Here is my cost basis in today's biotech buys: XON $29.99 SAGE $29.09 PTLA $29.29 OTIC $13.17 NVAX $4.53 NK...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.